Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Cantor Fitzgerald
Healthtrust
Cerilliant
Dow
Cipla
Federal Trade Commission
Baxter
Novartis
Mallinckrodt

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019937

« Back to Dashboard

NDA 019937 describes ADENOCARD, which is a drug marketed by Astellas and is included in one NDA. It is available from two suppliers. Additional details are available on the ADENOCARD profile page.

The generic ingredient in ADENOCARD is adenosine. There are twenty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.
Summary for 019937
Tradename:ADENOCARD
Applicant:Astellas
Ingredient:adenosine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019937
Mechanism of ActionAdenosine Receptor Agonists
Medical Subject Heading (MeSH) Categories for 019937
Suppliers and Packaging for NDA: 019937
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADENOCARD adenosine INJECTABLE;INJECTION 019937 NDA Astellas Pharma US, Inc. 0469-8234 0469-8234-14 10 SYRINGE, PLASTIC in 1 PACKAGE (0469-8234-14) > 4 mL in 1 SYRINGE, PLASTIC
ADENOCARD adenosine INJECTABLE;INJECTION 019937 NDA Astellas Pharma US, Inc. 0469-8234 0469-8234-12 10 SYRINGE, PLASTIC in 1 PACKAGE (0469-8234-12) > 2 mL in 1 SYRINGE, PLASTIC

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3MG/ML
Approval Date:Oct 30, 1989TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Federal Trade Commission
Fuji
McKinsey
US Army
Daiichi Sankyo
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot